BioUtah is pleased to provide the life sciences community with a current summary of state COVID-19 initiatives and grant programs managed by the Governor’s Office of Economic Development. Visit business.utah.gov/coronavirus to learn more. Coronavirus Prevention Messaging Grants Grants of up to $50,000, $75,000 or $250,000 for social media, targeted audience and mass media campaigns, respectively, […]
The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year. The plan would prioritze vaccines for healthcare workers, essential employees, and high-risk indiividuals. From there, distribution would be expanded to the broader population. The plan includes two documents: documents: A strategic distribution overview along with an interim […]
TestUtah has some new twists. Following the expiration of certain state contracts September 1, the Utah Department of Public Health has changed direction and contracted with a Los Angeles laboratory, Fulgent Genetics, to process COVID-19 testing for Utahns under the state’s coronavirus testing initiative. The test, which has received EUA from the FDA, will be […]
On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]
Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]
Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]
President Trump issued a new “Most-Favored-Nations” (MFN) executive order on September 13 that links U.S.-paid Medicare drug prices to those paid by other foreign countries. BIO President and CEO, Dr. Michelle McMurry-Heath, called the President’s action a “reckless scheme” that would hurt vulnerable seniors. The new order includes both Medicare Part B and Part D […]
In a double header of good news, Salt Lake City -based Recursion announced on Wednesday that the company has entered into a strategic collaboration agreement with Bayer to discover and develop new treatments for fibrotic diseases of the lung, kidney, heart and more. The agreement leverages Recursion’s AI drug discovery platform and Bayer’s small molecule […]
Co-Diagnostics, a Salt Lake City company that was out of the gate early with a molecular COVID-19 test, announced this week that it has entered into an agreement with another Salt Lake City based company, Arches Research, a CLIA laboratory and subsidiary of PolarityTE to expand Arches’ COVID-19 testing services using Co-Diagnostics’ Logix Smart™ COVID-19 […]
Horizon Therapeutics has been named to PEOPLE’s 2020 “50 Companies That Care” list. Partnering with Great Place to Work, PEOPLE identified the top U.S. companies that went above and beyond in responding to the pandemic.The list, focused on employers with 1,000 or more employees, will be featured in the Sept. 14, 2020 print issue of […]
The CEOs of nine pharmaceutical manufacturers working on COVID-19 vaccines – AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi – signed a pledge Tuesday to “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.” In the pledge, the […]
Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]
Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]
This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]
By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]
By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]
SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment vehicle. Participants in the round included existing investors, as well as new institutional investors from South Korea […]
HHS said yesterday that it has determined that the FDA will not require premarket review of laboratory-developed tests (LDTs) without notice-and-comment rulemaking. This means that the FDA cannot expand its authority over LDTs through guidance and other informal issuances. As reported by Genome Web, it also means that laboratories will be able to “offer LDTs […]
BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]
On August 11, Altitude Lab, founded by BioUtah member Recursion and the University of Utah’s Center for Technology & Venture Commercialization (TVC), announced its first resident companies and opened applications for its unique collaborative facility and program. The incubator, a state-of-the-art 14,500 square foot lab facility, will offer resident companies workshops, mentoring, and non-dilutive funding […]
After IPO issuances came to a near-halt in late Q1 and early Q2, the window reopened wide this summer, when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. Join us for a two-part executive webcast series on the novel challenges of capital raising during a […]
Shop In Utah: $35M (+ $10M added from ComRent) Opened Monday, July 27 – closed August 7, 2020, at 1:30 p.m. Shop in Utah number of applications received: 872 Shop in Utah total award amount requested: $42,344,434 Shop in Utah number of awards: 653 Shop in Utah total award amount: $26,790,444 Average award amount: $41,023 […]
Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]
Bipartisan legislation to help entrepreneurs and startups navigate the economic perils of COVID-19, has been introduced in the U.S. House of Representatives. The bill, the IGNITE American Innovation Act (H.R. 7917), introduced by Reps. Dean Phillips (D-MN) and Jackie Walorski (R-IN), will allow many small companies that have not benefited from CARES Act relief to […]
BioUtah members are eligible for an exclusive discounted rate on our premiere BIO Investor Forum Digital registration package! HOW IT WORKS: Anyone can fill out the form to request a 20% discount. They will receive a discount code via email upon completing the form. BIO will honor this code and rate up until showtime. Codes […]
Company Presentations are an integral programming element at BIO Investor Forum Digital that allow companies to discuss their pipeline, R&D activities, and future fundraising goals to this exclusive audience of investors and collaboration partners. Learn more and apply to present here.
Convergence is the largest annual gathering of regulatory professionals, regulators, scientists, and innovators from around the world and the only US event that is exclusively dedicated to the regulatory profession. And this year, the community will converge online with two virtual registration options that will allow attendees to experience Convergence live online from the safety […]
Take a quick lunch break to hear from Mike Leavitt (former U.S. Secretary of Health and Human Services and former Utah Governor) as he takes 20 minutes to discuss “Public Health: The Invisible Ingredient in Value-Based Care” in this free webinar. Learn more and register here.
This months Fulfillment Friday by NOW CFO features Michelle Lockhart. Michelle will presenting Healthy Hacks for Busy People. “As individuals, we each interpret success differently. But, no matter who you are, what your goal is and how you define success, one thing holds true: a healthy body and mind is essential if you want to […]
At a July 30 White House Roundtable, plasma industry leader and CSL Behring (CSL) CEO Paul Perreault, urged people who have recovered from COVID-19 to consider donating plasma to help develop a potential treatment for people with serious complications from COVID-19. Representing the plasma industry, Perreault pointed to the unprecedented CoVIg-19 Plasma Alliance – an […]
Earlier this week, Senate Majority Leader Mitch McConnell released the Republican version of a fourth COVID-19 package (or as some say, a second round of a CARES Act stimulus bill). The bill, titled the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act is actually a collection of bills. Highlights include another round of $1200 […]
Last Friday, President Trump signed four executive orders aimed at lowering drug prices, including an order that would set up a “most favored nation” (MFN) pricing model for Medicare Part B drugs, effectively imposing foreign price controls on critical medicines for seniors. The goal, Trump said, is to “end global freeloading on the backs of […]
